𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacologic Options for Aggressive Low-Density Lipoprotein Cholesterol Lowering: Benefits Versus Risks

✍ Scribed by James M. McKenney

Book ID
113442247
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
106 KB
Volume
96
Category
Article
ISSN
0002-9149

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effects of Ezetimibe Added to Atorvastat
Effects of Ezetimibe Added to Atorvastatin Versus Atorvastatin Up-Titration on Attainment of Single and Dual Levels for Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol, Apolipoprotein B, or High-Sensitivity C-Reactive Protein in Older Adults with High Coronary Heart Disease Risk
✍ Christian Constance; Ori Ben-Yehuda; Nanette K. Wenger; Franklin Zieve; Jianxin πŸ“‚ Article πŸ“… 2010 πŸ› Elsevier 🌐 English βš– 50 KB
Relationship of Oxidized Phospholipids a
Relationship of Oxidized Phospholipids and Biomarkers of Oxidized Low-Density Lipoprotein With Cardiovascular Risk Factors, Inflammatory Biomarkers, and Effect of Statin Therapy in Patients With Acute Coronary Syndromes: Results From the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) Trial
✍ Alexander E. Fraley; Gregory G. Schwartz; Anders G. Olsson; Scott Kinlay; Michae πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 561 KB